Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts

被引：0
|
作者：
F. Guffanti
M F Alvisi
A. Anastasia
F. Ricci
M. Chiappa
A. Llop-Guevara
V. Serra
R. Fruscio
A. Degasperi
S. Nik-Zainal
M R Bani
M. Lupia
R. Giavazzi
E. Rulli
G. Damia
机构：
[1] Istituto di Ricerche Farmacologiche Mario Negri IRCCS,Laboratory of Molecular Pharmacology, Department of Oncology
[2] Istituto di Ricerche Farmacologiche Mario Negri IRCCS,Laboratory of Methodology for Clinical Research, Department of Oncology
[3] Istituto di Ricerche Farmacologiche Mario Negri IRCCS,Laboratory of Cancer Metastasis Therapeutics, Department of Oncology
[4] Vall d’Hebron Institute of Oncology,Experimental Therapeutics Group
[5] University of Milan Bicocca,Clinic of Obstetrics and Gynecology, Department of Medicine and Surgery, San Gerardo Hospital
[6] University of Cambridge,MRC Cancer Unit, Hutchison/MRC Research Centre
[7] Addenbrooke’s Hospital,Academic Laboratory of Medical Genetics, Lv 6 Addenbrooke’s Treatment Centre
[8] IEO,Unit of Gynecological Oncology Research
[9] European Institute of Oncology IRCCS,undefined
来源：
British Journal of Cancer | 2023年 / 128卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1405 / 1405
相关论文
共 50 条
  • [41] Genomic analysis of recurrent ovarian cancer in patient-derived xenografts treated with platinum and taxane chemotherapy
    Stover, Elizabeth
    Amin-Mansour, Ali
    Palakurthi, Sangeetha
    Dharma, Sanam
    Zeng, Qing
    Zhou, Shan
    Desai, Palak
    Garraway, Levi
    Matulonis, Ursula
    Liu, Joyce
    CANCER RESEARCH, 2017, 77
  • [42] Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein
    Alaa Tarig Alshareeda
    Ola H. Negm
    Mohammed A. Aleskandarany
    Andrew R. Green
    Christopher Nolan
    Patrick J. TigHhe
    Srinivasan Madhusudan
    Ian O. Ellis
    Emad A. Rakha
    Breast Cancer Research and Treatment, 2016, 159 : 41 - 53
  • [43] EGFR gene status predicts response and survival benefit in a preclinical gastric cancer trial treating patient-derived xenografts with cetuximab
    Wang, Xiaohong
    Fu, Runjia
    Hu, Ying
    Du, Hong
    Li, Shuangxi
    Li, Ziyu
    Liu, Yiqiang
    Li, Qixiang
    Zhang, Lianhai
    Ji, Jiafu
    ONCOLOGY REPORTS, 2017, 38 (04) : 2387 - 2393
  • [44] Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein
    Alshareeda, Alaa Tarig
    Negm, Ola H.
    Aleskandarany, Mohammed A.
    Green, Andrew R.
    Nolan, Christopher
    TigHhe, Patrick J.
    Madhusudan, Srinivasan
    Ellis, Ian O.
    Rakha, Emad A.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 41 - 53
  • [45] Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomes
    Alizzi, Zena
    Saravi, Sayeh
    Khalique, Saira
    McDonald, Thirza
    Karteris, Emmanouil
    Hall, Marcia
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (09) : 1427 - 1433
  • [46] Correction to: In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
    Eric P. Souto
    Lacey E. Dobrolecki
    Hugo Villanueva
    Andrew G. Sikora
    Michael T. Lewis
    Journal of Mammary Gland Biology and Neoplasia, 2022, 27 : 231 - 231
  • [47] Automated scoring to assess RAD51-mediated homologous recombination in patient-derived tumor organoids of ovarian cancers
    Thorel, Lucie
    Morice, Pierre-Marie
    Elie, Nicolas
    Weiswald, Louis-Bastien
    Florent, Romane
    Giffard, Florence
    Jacobs, Margaux
    Ricou, Agathe
    Leman, Raphael
    Babin, Guillaume
    Lebrun, Jean-Francois
    Martin, Sandrine
    Briand, Melanie
    Goudergues, Benoit
    Lambert, Bernard
    Blanc-Fournier, Cecile
    Vaur, Dominique
    Plancoulaine, Benoit
    Poulain, Laurent
    CANCER RESEARCH, 2023, 83 (07)
  • [48] The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases
    Anastasia, Alessia
    Dellavedova, Giulia
    Ramos-Montoya, Antonio
    James, Neil
    Chiorino, Giovanna
    Russo, Massimo
    Baakza, Hana
    Wilson, Joanne
    Ghilardi, Carmen
    Cadogan, Elaine B.
    Giavazzi, Raffaella
    Bani, Maria Rosa
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (04) : 555 - 567
  • [49] Investigations on the role of epithelial-mesenchymal transition and cancer stem cells in the response to therapy in patient-derived ovarian carcinoma xenografts
    Ricci, Francesca
    Guffanti, Federica
    Fratelli, Maddalena
    Massimo, Broggini
    Damia, Giovanna
    CANCER RESEARCH, 2015, 75
  • [50] Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis
    Wang, Yen-Yun
    Cheng, Kuang-Hung
    Hung, Amos C.
    Lo, Steven
    Chen, Pang-Yu
    Wu, Yi-Chia
    Hou, Ming-Feng
    Yuan, Shyng-Shiou F.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2024, 64 (02)
12345